Table 2.
Peri-surgical treatment
|
Preoperative treatment
|
|
|
| No treatment | 24 | |
| TAI | 4 | |
| TAI + ERT | 1 | |
| TAI + TKI1 + ERT | 1 | |
| Postoperative treatment | Total | POCR (+) |
| TAI + hepatectomy + lung resection + chemo | 1 | 1 |
| Hepatectomy + chemo + TAI + ERT | 1 | 1 |
| Lung resection + LAT + TAI + chemo + ERT | 1 | 1 |
| Lung resection + LAT | 1 | 0 |
| Brain tumor resection + TAI + TKI2 + chemo + ERT | 1 | 0 |
| LAT + TAI + ERT | 2 | 2 |
| TAI + TKI3 + chemo ( + ERT) | 3 | 0 |
| TAI + TKI4 | 2 | 0 |
| TAI + chemo ( + ERT) | 6 | 1 |
| TAI ( + ERT) | 9 | 2 |
| ERT | 1 | 0 |
| No treatment | 1 | 0 |
| Unknown | 1 | 0 |
| Total | 30 | 8 |
1
TKI: Sorafenib (n = 1).
2
TKI: Sorafenib (n = 1).
3
TKI: Sorafenib (n = 1), lenvatinib (n = 1), sorafenib + lenvatinib (n = 1).
4
TKI: Sorafenib (n = 1), sorafenib + lenvatinib (n = 1). TAI: Transarterial infusion; ERT: External beam radiotherapy; TKI: Tyrosine kinase inhibitors; LAT: Local ablation therapy.